Publications by authors named "H Maekawa"

The combination therapy of lenvatinib plus pembrolizumab (LP) is increasingly recognized as an important second-line regimen for advanced or recurrent endometrial cancer (EC). However, the safety and efficacy of conversion surgery with low anterior rectal resection for unresectable EC following LP therapy is unknown. A 37-year-old woman was referred with unresectable EC with pleural fluid, peritoneal dissemination, and ascites.

View Article and Find Full Text PDF

An aberrant right subclavian artery (ARSA) is a rare vascular anomaly accompanied by nonrecurrent inferior laryngeal nerve (NRILN). Here, we described the cervical-first approach in thoracoscopic esophagectomy for an esophageal cancer patient with ARSA using the intraoperative nerve monitoring (IONM) system. First, a left cervical procedure proceeded to expose the left vagus nerve to attach the APS electrode of the IONM system, and the left cervical paraesophageal lymph nodes was dissected separately.

View Article and Find Full Text PDF

Radical surgery for rectal cancer with bulky lateral pelvic lymph node (LPLN) metastasis involving the sciatic nerve presents both technical and oncological challenges. Preoperative multidisciplinary treatments have recently been anticipated to control the disease as well as to preserve organ function. A 51-year-old man, presenting with right buttock pain and impairment of walking, was diagnosed with sciatic nerve impairment due to right LPLN metastasis from rectal cancer.

View Article and Find Full Text PDF

Protein trafficking to vacuoles in plants and fungi, and to lysosomes in animals, is essential for the maintenance of cellular homeostasis. In Saccharomyces cerevisiae, the vacuolar protein sorting (VPS) pathway has been well studied by using vacuolar carboxypeptidase Y (CPY) as a model, and many VPS genes have been identified. By contrast, the vacuolar protein trafficking pathway in Schizosaccharomyces pombe remains poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with hepatocellular carcinoma (HCC) and extrahepatic metastasis generally have a poor prognosis, but combination therapy with atezolizumab and bevacizumab (ATZ/BEV) shows strong antitumor efficacy.
  • A 74-year-old man with a history of HCC faced severe complications, including rectovesical pouch dissemination, but responded well to ATZ/BEV treatment despite needing to discontinue bevacizumab due to fistula formation.
  • After a year of treatment, the tumors shrank significantly, allowing for curative robot-assisted surgery which confirmed the successful removal of the HCC with clear margins.
View Article and Find Full Text PDF